# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(0.01) per share. This is a 87.5 percent increase over losses o...
Galera Therapeutics shares are trading lower by 34.8% during Monday's session. The company said its shares will be delisted...